The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

The field of thrombosis is at the forefront of personalized healthcare. Thrombophilia refers to hereditary conditions that predispose patients to the risk of thromboembolism. [13] As early as 1994, ...

Small blood clots called emboli are mostly known for traveling through the vasculature before they lodge and obstruct vessels, impeding blood and oxygen supply to organs like the lung. To stop ...

Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...

Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...

A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim trial ...

A European medical regulator says it has found a possible link to the cause of the extremely rare blood clot disorder, tied to the Johnson and Johnson vaccine. It's the potential finding that medical ...

King Faisal Specialist Hospital & Research Centre continues to advance pediatric care through specialized programs dedicated to solid tumors and non-malignant blood disorders, supported by ...

A dangerous blood clot has taken San Antonio Spurs’ Victor Wembanyama out of play for the rest of the 2024-2025 basketball season, the NBA announced Thursday.Wembanyama, a 21-year-old French ...